NGNE EPS Estimates
Neurogene Inc.
$23.44
+$1.26(+5.68%)
38
Overall
--
Value
45
Tech
31
Quality
Market Cap
$443.85M
Volume
42.43K
52W Range
$15.93 - $43.66
Target Price
$77.22
NGNE EPS estimates: the consensus estimate for Neurogene Inc.'s current fiscal year is -$5.88 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NGNE EPS Estimates
- EPS estimate, current quarter
- $-1.49
- EPS estimate, next quarter
- $-1.47
- EPS estimate, current year
- $-5.88
- EPS estimate, next year
- $-6.23
- EPS growth, 3-year
- -0.64%
| Fiscal year | EPS |
|---|---|
| 2025 | $-4.24 |
| 2024 | $-4.28 |
| 2023 | $-73.82 |
| 2022 | $-4.16 |
| 2021 | $-4.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NGNE | $23.44 | +5.7% | 42.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |